StockData
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

BIO-TECHNE Corp

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 24, 2026
$72.49−0.08 (-0.11%)

Close on Oct 19, 2026

Market cap
$11.40B
P/E (TTM)
62.5
Dividend yield
0.44%

Bio-Techne statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison

Valuation

MeasureBio-TechneIndustry median
Market Cap$11.37B$197.05M
Enterprise Value$11.30B$106.56M
PE Ratio62.4920.52
PS Ratio9.363.93
PB Ratio5.392.14
P/TBV Ratio13.712.46
P/FCF Ratio43.1918.25
P/OCF Ratio38.9213.78

Enterprise value

MeasureBio-TechneIndustry median
EV / Sales9.302.69
EV / EBITDA32.3614.86
EV / EBIT44.8719.00
EV / FCF42.9421.02

Income (trailing twelve months)

MeasureBio-TechneIndustry median
Revenue$1.22B$57.94M
Gross Profit$799.07M$90.47M
Operating Income$251.89M-$21.44M
Pretax Income$240.68M-$14.45M
EBITDA$349.25M-$16.91M
EPS (Diluted)$1.16-$0.83

Margins

MeasureBio-TechneIndustry median
Gross Margin65.8%52.3%
Operating Margin20.7%-44.5%
Pretax Margin19.8%-13.0%
EBITDA Margin28.7%-31.3%
FCF Margin21.7%-8.85%

Returns

MeasureBio-TechneIndustry median
Return on Invested Capital (ROIC)9.18%-32.0%
Return on Capital Employed (ROCE)10.4%-37.8%

Growth

MeasureBio-TechneIndustry median
Revenue Growth (YoY)-0.38%6.01%
EPS Growth (YoY)152.2%-29.2%
FCF Growth (YoY)2.60%2.34%
Revenue Growth (3Y CAGR)2.25%2.25%
Revenue Growth (5Y CAGR)5.47%6.42%
EPS Growth (3Y CAGR)-13.0%-0.17%
EPS Growth (5Y CAGR)5.92%3.77%

Balance sheet

MeasureBio-TechneIndustry median
Cash & Short-Term Investments$264.71M$62.42M
Total Debt$200.00M$120.13M
Net Cash (Debt)$64.71M$15.68M
Net Cash Per Share$0.41$0.65
Equity (Book Value)$2.11B$48.79M
Book Value Per Share$13.44$1.36
Tangible Book Value$829.40M$23.06M
Working Capital$580.70M$75.77M

Financial position

MeasureBio-TechneIndustry median
Current Ratio4.553.30
Quick Ratio2.942.39
Debt / Equity0.090.51
Debt / EBITDA0.573.35
Debt / FCF0.765.05
Net Debt / EBITDA-0.192.22
Interest Coverage26.16-7.12

Cash flow (trailing twelve months)

MeasureBio-TechneIndustry median
Operating Cash Flow$292.07M-$12.35M
Capital Expenditures-$28.85M-$1.06M
Free Cash Flow$263.22M-$20.28M
FCF Per Share$1.68-$0.41

Efficiency

MeasureBio-TechneIndustry median
Asset Turnover0.470.38
Inventory Turnover2.162.67
Revenue Per Employee$405.01K$398.96K
Employee Count3,00073

Dividends and yields

MeasureBio-TechneIndustry median
FCF Yield2.32%-7.64%
Dividend Yield0.44%1.83%
Buyback Yield0.37%-0.58%
Shareholder Yield0.81%0.00%
Dividend Per Share$0.32$0.83
Dividend Growth (YoY)0.00%2.37%
Years of Dividend Growth00
FCF Payout Ratio19.0%51.6%

Shares

MeasureBio-TechneIndustry median
Shares Outstanding156,818,00059,128,900
Shares Change (YoY)-1.70%11.1%
Shares Change (QoQ)-0.27%0.54%
Float156,276,00048,744,500
Shares Held by Insiders0.35%11.8%
Shares Held by Institutions111.8%59.4%

Taxes

MeasureBio-TechneIndustry median
Income Tax$58.82M$91.50K
Effective Tax Rate24.4%20.6%

Scores

MeasureBio-TechneIndustry median
Graham Number$18.73$17.36
Graham Upside-74.2%-45.5%
Altman Z-Score15.930.10
Beneish M-Score-2.52-2.62

Calculated by StockData from Bio-Techne's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.